Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dull

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Microbiology|August 6, 2005
High level of sequence diversity in the 16S rRNA genes of Haemophilus influenzae isolates is useful for molecular subtypingClaudio T Sacchi, Dietmar Alber, Peter Dull, et al.
Vaccine|January 3, 2025
Meeting summary: Global vaccine and immunization research forum, 2023Birgitte Giersing, Annie X Mo, Angela Hwang, et al.
Vaccines|October 23, 2020
Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-AnalysisAndrew M Secor, Matthew Driver, Brenda Kharono, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
Vaccine|March 2, 2016
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant womenGeert Leroux-Roels, Cathy Maes, Julie Willekens, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Human Vaccines|July 8, 2011
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adultsDaniela Toneatto, Philipp Oster, A Corine W deBoer, et al.
Vaccine|February 21, 2023
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021Andrew Ford, Angela Hwang, Annie X Mo, et al.
Clinical Trials (London, England)|July 2, 2016
ResponseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.
Clinical Trials (London, England)|January 16, 2016
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Microbiology|August 6, 2005
High level of sequence diversity in the 16S rRNA genes of Haemophilus influenzae isolates is useful for molecular subtypingClaudio T Sacchi, Dietmar Alber, Peter Dull, et al.
Vaccine|January 3, 2025
Meeting summary: Global vaccine and immunization research forum, 2023Birgitte Giersing, Annie X Mo, Angela Hwang, et al.
Vaccines|October 23, 2020
Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-AnalysisAndrew M Secor, Matthew Driver, Brenda Kharono, et al.
Vaccine|July 2, 2021
Evidence for antibody as a protective correlate for COVID-19 vaccinesKristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, et al.
Vaccine|March 2, 2016
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant womenGeert Leroux-Roels, Cathy Maes, Julie Willekens, et al.
Vaccine|December 4, 2016
A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccineRobert C Read, Peter Dull, Xilian Bai, et al.
Human Vaccines|July 8, 2011
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adultsDaniela Toneatto, Philipp Oster, A Corine W deBoer, et al.
Vaccine|February 21, 2023
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021Andrew Ford, Angela Hwang, Annie X Mo, et al.
Clinical Trials (London, England)|July 2, 2016
ResponseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.
Clinical Trials (London, England)|January 16, 2016
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.
Pageof 4